Calcified vessels – balloons that cut Azfar Zaman Freeman Hospital, Newcastle-upon-Tyne.

Slides:



Advertisements
Similar presentations
Clinical Trial Results. org ABSORB Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Patrick W. Serruys.
Advertisements

TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
PCI Unmet Clinical Needs
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
BIFURCATION LESIONS Dr. Tahsin.N
Plaque Debulking Prior to Stenting Dr. Layth A. Mimish The Cardiovascular Consultants Group Jeddah, Saudi Arabia.
Optimal Stent Expansion and Optimization
Angioplasty’s Fight against Restenosis: Drug Eluting Stents & Bare Metal Stents.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.
M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.
C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Technical approach PCI in Small Vessels Washington Cardiology Center Augusto Pichard, L. Satler, K. Kent, R. Waksman, J. Laird, W. Suddath, J. Sharretts,
Confidential: Internal Use only 1 Click to edit Master title style Click to edit Master text styles – Second level Third level – Fourth level » Fifth level.
When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.
Radiation for restenosis: the dark side of arteries Robert S Schwartz MD Professor of Medicine Mayo Clinic Rochester, MN.
Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons Presented at The American Heart Association Scientific Session 2006 Presented by Dr.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
Which is the role of post-dilation after DES implantation? Enrico Romagnoli 1,2 M.D., Ph.D. 1 Policlinico Casilino, Roma 2 Opedale San Raffaele, Milano.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
Cardiac catheterization Labs
Need Statement and Need Criteria. Need Statement To prevent the reoccurrence of stenosis in coronary arteries. More specifically, to create a solution.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Intervention of Aortic Coarctation: from Angioplasty to Stent
The First Affiliated Hospital of Harbin Medical University
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention Lisette Okkels Jensen,
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Global Experience with Peripheral DCBs/Stent Studies: C.R. Bard
Disrupt CAD Study Design
Alaa gabi, md sUPERVISOR: RAMEEZ SAYYED, MD.
My initial ABSORB experience Assoc. Prof. I. Petrov
Abbott Vascular Bifurcation Program
Clinical Usefulness of Post-Stenting FFR
Regulatory Challenges for Bioasorbable Stent Approval
From: Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal StentsThe TAXUS V ISR Randomized Trial JAMA. 2006;295(11):
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
Paclitaxel Drug-Coated Balloons for De Novo Lesions
Strategy planning in coronary bifurcation stenting
Bioabsorbable DES and Biodegradable Polymers – FDA View
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Future Directions and Development of DCB Systems
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Subintimal Tracking and Reentry for CTO STAR Method
Long-Term Survival Benefit of DCB Versus DES for ISR Despite Angiographic Disadvantage of DCB Bruno Scheller Klinische und Experimentelle Interventionelle.
OCT-Guided PCI What needs to be done to establish criteria?
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Circ Cardiovasc Interv
Catheter-Based Treatment of Coronary Artery Disease
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Using Coronary CTA to Guide Intervention for CTO
SKS Technique Clinical Case
Bifurcation Disease: Simulation Training Curriculum
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
SMART-STRATEGY Trial design: Patients with a bifurcation coronary lesion were randomized to a conservative strategy (n = 128) vs. an aggressive strategy.
Maintenance of Long-Term Clinical Benefit with
Presentation transcript:

Calcified vessels – balloons that cut Azfar Zaman Freeman Hospital, Newcastle-upon-Tyne

Indication?

Cutting balloon What? What? Why? Why? When? When? How? How?

Cutting balloons – What? non compliant balloons non compliant balloons with cutting tomes or wires on balloon to score plaque with cutting tomes or wires on balloon to score plaque monorail monorail

- Angiosculpt Cutting balloon Flextome

Angiosculpt

Semi-compliant balloon, dual wires exert focused inflation force Facilitate controlled plaque fractures - creation of focused force in a localized region of the plaque Scoreflex

Why? Precise dilatation 5,8 Precise dilatation 5,8 Scores plaque by severing the elastic and fibrotic continuity of vessel wall 8 Scores plaque by severing the elastic and fibrotic continuity of vessel wall 8 Dilatation at lower pressures with less recoil compared to POBA 9,5 Dilatation at lower pressures with less recoil compared to POBA 9,5 Lumen gain through plaque compression instead of vessel wall expansion 5,6,7 Lumen gain through plaque compression instead of vessel wall expansion 5,6,7 Vessel preparation prior to stent placement reduces mal- apposition 10 Vessel preparation prior to stent placement reduces mal- apposition 10 Lower residual percent diameter stenosis with CB TM + stent v POBA + stent, post procedure and 6 months follow-up. 11 Lower residual percent diameter stenosis with CB TM + stent v POBA + stent, post procedure and 6 months follow-up. 11 No slippage on deployment 3 No slippage on deployment 3 Minimal plaque shift 5,6,7 Minimal plaque shift 5,6,7 Low rates of acute complications POBA. 3 Low rates of acute complications POBA. 3

creates controlled incision planes which help to relieve hoop stress allows dilatation at lower pressures CB POBA Why?

Cutting balloons – when?  In-Stent Restenosis Lesions - Avoid balloon slippage Lesions with a high composition of neo-intimal hyperplasia offer greater resistance to dilatation and cause balloon slippage 1,2Lesions with a high composition of neo-intimal hyperplasia offer greater resistance to dilatation and cause balloon slippage 1,2 The scoring mechanism allows controlled dilatation while preventing balloon slippage 3.The scoring mechanism allows controlled dilatation while preventing balloon slippage 3.  Ostial and Bifurcation Lesions - Avoid Plaque shift Challenging lesions with a higher degree of recoil and potential of plaque shiftChallenging lesions with a higher degree of recoil and potential of plaque shift Cutting Balloons dilate while reducing elastic recoil 4 and allowing more plaque compression with minimal plaque shift 5,6,7Cutting Balloons dilate while reducing elastic recoil 4 and allowing more plaque compression with minimal plaque shift 5,6,7  Fibrotic lesions - Change lesion compliance Resistant lesions with a higher concentration of elastin and muscle fibersResistant lesions with a higher concentration of elastin and muscle fibers Cutting Balloon T score through fibrotic plaque providing a strategy for coronary lesions resistant to conventional balloon dilatation 15Cutting Balloon T score through fibrotic plaque providing a strategy for coronary lesions resistant to conventional balloon dilatation 15

When? Indications: Indications: Discrete (<15 mm in length), or tubular (10 to 20 mm in length) Reference vessel diameter (RVD) of 2.00 mm mm Light to moderate tortuosity of proximal vessel segment Nonangulated lesion segment (< 45°) Absence of angiographically visible thrombus Contraindications: Contraindications: Avoid passing through struts of previously deployed stent. Deflated balloon could become entangled in the stent on withdrawal.Avoid passing through struts of previously deployed stent. Deflated balloon could become entangled in the stent on withdrawal. Warnings: Warnings: When treating bifurcations, CB can be used prior to placing a stent, but not taken through the side cell of a stentWhen treating bifurcations, CB can be used prior to placing a stent, but not taken through the side cell of a stent Calcified vessel?

Bifurcations NICECUT NICECUT “Cutting-balloon angioplasty effectively facilitates the interventional procedure and leads to a low rate of recurrent stenosis in ostial bifurcation coronary lesions: It is associated with a low rate of binary stenosis and TLR. ”

In-stent restenosis RESCUT RESCUT CBA did not reduce recurrent ISR and major adverse cardiac events, as compared with conventional POBA. However, CBA was associated with procedural advantages, such as use of fewer balloons, less requirement for additional stenting, and lower incidence of balloon slippage.

How? Selecting diameter Selecting diameter Balloon to artery ratio should not exceed 1.1:1.0 (in vessels ≥ 3.0 mm)Balloon to artery ratio should not exceed 1.1:1.0 (in vessels ≥ 3.0 mm) For vessels < 3.00 mm; 1:1 more appropriateFor vessels < 3.00 mm; 1:1 more appropriate If using IVUS, measure media to media and maintain 1:1 balloon to artery ratioIf using IVUS, measure media to media and maintain 1:1 balloon to artery ratio Selecting length Selecting length Shorter lengths easier to deliver in tortuous anatomy than longer lengthsShorter lengths easier to deliver in tortuous anatomy than longer lengths Re-inflation along length of lesion acceptableRe-inflation along length of lesion acceptable

How? Guide catheterGuide catheter ideally 6F ideally 6F Guide wireGuide wire moderate to extra support moderate to extra support hydrophilic coating may be helpful hydrophilic coating may be helpful 20 cc syringe filled with diluted contrast20 cc syringe filled with diluted contrast 3-way stopcock3-way stopcock

Data? REDUCE III clinical trial ( Ozaki, Y, et al. Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal. 2007; 71:1-8 ) REDUCE III clinical trial ( Ozaki, Y, et al. Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal. 2007; 71:1-8 ) WINNER Registry ( Taniuchi et al. The WINNER registry, Catheter Cardiovasc Interv 2004;62C-36 ) WINNER Registry ( Taniuchi et al. The WINNER registry, Catheter Cardiovasc Interv 2004;62C-36 ) NICECUT : Int J Cardiol Mar 14;124(3): NICECUT : Int J Cardiol Mar 14;124(3): RESCUT : J Am Coll Cardiol. 2004;43(6):943-9 RESCUT : J Am Coll Cardiol. 2004;43(6):943-9

Conclusion (1 of 2) Cutting or “scoring” balloons: are safe are safe paucity of data confirming clinical benefits paucity of data confirming clinical benefits procedural benefits procedural benefits relatively (laser/rota) simple to use relatively (laser/rota) simple to use cheaper than laser/rota cheaper than laser/rota limited indications for use limited indications for use

Conclusion (2 of 2) Cutting (or scoring) balloons effective for resistant fibrotic lesions resistant fibrotic lesions in-stent restenosis in-stent restenosis and finally…..calcified vessels? and finally…..calcified vessels? Yes, but only in mild to moderate calcified arteries with minimal vessel/lesion tortuosity to favourably alter vessel compliance

Thank you

Glossary 1. Kurbaan et al, Cutting Balloon Angioplasty for In-Stent Restenosis, Catheterization and Cardiovascular Interventions 50: (2000) 1. Kurbaan et al, Cutting Balloon Angioplasty for In-Stent Restenosis, Catheterization and Cardiovascular Interventions 50: (2000) 2. Alfonso F., Should we use the Cutting Balloon in Patients With In-Stent Restenosis?, JACC Vol 44, No 12, 2004, Dec 21, 2004: Alfonso F., Should we use the Cutting Balloon in Patients With In-Stent Restenosis?, JACC Vol 44, No 12, 2004, Dec 21, 2004: Taniuchi et al. The WINNER registry, Catheter Cardiovasc Interv 2004;62C Taniuchi et al. The WINNER registry, Catheter Cardiovasc Interv 2004;62C Inoue et al. J Interven Cariol. 2003;13: Inoue et al. J Interven Cariol. 2003;13: Hara et al. AM. J Cardiol 2002;89: Hara et al. AM. J Cardiol 2002;89: Yamaguchi et al. J Interven Cardiol 1998; 11(Suppl) S114-S119 6.Yamaguchi et al. J Interven Cardiol 1998; 11(Suppl) S114-S Suzuki et al. Amer J Cardiol 1999; 84 Suppl;58P 7. Suzuki et al. Amer J Cardiol 1999; 84 Suppl;58P 8. Bonan, J Invasic Cardiol, 1999; 11: Bonan, J Invasic Cardiol, 1999; 11: Ergene et al, J Invas Cardiol, 1998;10: Ergene et al, J Invas Cardiol, 1998;10: Rizik, et al Benefits of Cutting Balloon Before Stenting J. Invas Cardiol 2003;15: Rizik, et al Benefits of Cutting Balloon Before Stenting J. Invas Cardiol 2003;15: Ozaki, Y, et al. Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal. 2007; 71: Ozaki, Y, et al. Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal. 2007; 71: Mathias DW et al. Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel.Am J Cardiol Mar1; 67(6): Mathias DW et al. Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel.Am J Cardiol Mar1; 67(6): Muramatsu et al. J Invas Cardiol 1999;11: Muramatsu et al. J Invas Cardiol 1999;11: Van Mieghem et al, Detection and Characterization of coronary bifurcation lesions with 64-slice computed topography coronary angiography, July 2007, EHJ Online, 14.Van Mieghem et al, Detection and Characterization of coronary bifurcation lesions with 64-slice computed topography coronary angiography, July 2007, EHJ Online, Bertrand et al, Management of Resistant Coronary Lesions by the Cutting Balloon Catheter: Initial Experience, Catheterization and Cardiovascular Diagnosis 41: (1997) 15. Bertrand et al, Management of Resistant Coronary Lesions by the Cutting Balloon Catheter: Initial Experience, Catheterization and Cardiovascular Diagnosis 41: (1997)